Dr. Ryan Flannigan

Dr. Ryan Flannigan

B.Sc. (Hon) University of Calgary
M.D. University of Calgary
Urology Residency, University of British Columbia
Male Reproduction, Microsurgery and Sexual Medicine Fellowship, Weill Cornell Medicine & Memorial Sloan Kettering, New York, NY

Team: 
Clinical and Research Scientists
Positions: 

Assistant Professor, Department of Urologic Sciences, University of British Columbia
Senior Research Scientist, Vancouver Prostate Centre
Director of Male Reproduction & Sexual Medicine Research Program, Department of Urologic Sciences, University of British Columbia
Adjunct Assistant Professor, Weill Cornell Medicine, New York, NY

 

Dr. Ryan Flannigan completed his fellowship training in Male Reproduction, Microsurgery and Sexual Medicine at the world-renowned Weill Cornell Medicine and Memorial Sloan Kettering Center in New York, NY.

Dr. Flannigan’s research program is focused on evaluating genetic and molecular mechanisms contributing to non-obstructive azoospermia (NOA), using precision single-cell strategies and in vitro methods. During fellowship training, he evaluated the role of microRNA-202-5p in Sertoli Cell Only Syndrome (supported by the AUA Care Foundation) and the roles of Y-Box Binding proteins in Maturation Arrest histologic subtypes. Presently, Dr. Flannigan is continuing his work evaluating the genetic and molecular mechanisms contributing to NOA focusing on techniques that facilitate cell-specific evaluation and functional interactions, with the goal of identifying novel therapeutic targets to treat men with no presently available treatments. Dr. Flannigan is also working to identify the molecular underpinnings underlying Peyronies Disease, with hopes of identifying novel therapeutic strategies. Beyond bench science, Dr. Flannigan is involved in numerous clinical trials and is actively involved in research related to preventative health and health promotion jointly with the Canadian Men’s Health Foundation.

Clinically, Dr. Flannigan is specialized in male infertility and sexual medicine. Dr. Flannigan evaluates men with all presentations of infertility, manages men both medically and surgically. He performs microsurgical varicocele repairs, microdissection testicular sperm extraction (microTESE), percutaneous sperm retrievals, electro ejaculation for men with spinal cord injuries and microsurgical vasectomy reversals including both the micro-dot vasovasostomy and vasoepididymostomy procedures, among others. Dr. Flannigan also performs no-scalpel vasectomies. Dr. Flannigan evaluates and treats men with Peyronies disease, erectile dysfunction, ejaculatory dysfunction and spinal cord injury associated infertility and sexual dysfunction. Dr. Flannigan performs penile implant surgery, Peyronies injections, Peyronies plications as well as excision and grafting techniques.

 

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Conference Flyer Page 1

Breast & Prostate Cancer half-day virtual conference: Saturday, September 18th, 2021

The What you Need to Know for Your Patients Post Breast & Prostate Cancer Conference, taking place online on Saturday, September 18th, 2021 from 8:00am – 1:30pm, is an accredited virtual half-day conference focusing on screening, treatment, side-effect management & emerging new therapies for breast & prostate cancer patients. Click here for more information and to register. 

Dr. Peter Black, team captain

Terry Fox Run fundraiser: September 19th, 2021

The 41st Annual Terry Fox Run is taking place on Sunday September 19, 2021. If you are able, please consider donating to our team (tax receipts issued), raising funds for the Terry Fox Foundation's ground-breaking cancer research. 

Employment

Work at the Vancouver Prostate Centre

Wednesday, September 8, 2021

Recent publication proposes a potential new therapeutic approach to treatment-resistant prostate cancer

Tuesday, August 3, 2021

Dr. Cherkasov receives 2021 Faculty of Medicine Distinguished Achievement Award

Dr. Cherkasov